Contrast Agents for Imaging: Past, Present and Future

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Medicinal Chemistry".

Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 809

Special Issue Editors

Department of Chemistry, University of Coimbra, Rua Larga, 3004-535 Coimbra, Portugal
Interests: medicinal chemisry; medical imaging; synthesis; inorganic chemistry
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Chemistry, University of Coimbra, Coimbra, Portugal
Interests: organic synthesis; CO2-based polymeric materials; medicinal chemistry; sustained catalytic processes
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

According to the World Health Organization (WHO), cancer is one of the major causes of mortality worldwide, with 18 million new cases (10 million deaths) in 2018, and is projected to account for 17 million deaths annually by 2030. There are several strategies that can be used to overcome this huge problem, namely, the development of imaging techniques and contrast agents with greater resolution and sensitivity, aiming at early detection. This Special Issue on “Contrast Agents for Imaging: Past, Present and Future” invites researchers to contribute with original research or review papers related to the design/development of contrast agents for Imaging. This Special Issue intends to summarize the state of the art and the latest findings in the contrast agent field, as well as to propose future directions for this area. Contributions may include the synthesis of new contrast agents, characterization, its evaluation for the imaging technique, and in vitro and in vivo studies.

Dr. Sara Pinto
Prof. Dr. Mariette M. Pereira
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • contrast agent
  • medical imaging
  • radiolabeling
  • paramagnetic
  • magnetic resonance imaging
  • positron emission tomography
  • optical imaging

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop